For the Inventor, By the Inventor

Enter assignee name

Aventis Pasteur S.a.

USPTO Granted Patents = 17

% Expired Patents = 64.7

Forward Citations = 178

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Michel Chevalier (6 out of 9 patents)

Jean Haensler (3 out of 13 patents)

Monique Moreau (3 out of 10 patents)

4. Tino Krell (3 out of 3 patents)

5. Alain Françon (2 out of 8 patents)

6. Jorge Ronco (2 out of 2 patents)

7. Philippe Talaga (1 out of 10 patents)

8. Noëlle Mistretta (1 out of 9 patents)

9. Raphaëlle Claude El Habib (1 out of 2 patents)

10. Régis Sodoyer (1 out of 4 patents)

11. Catherine Moste (1 out of 4 patents)

12. Emilie Danve (1 out of 1 patent)

13. Robert Brasseur (1 out of 6 patents)

14. Patricia Sepulcri (1 out of 1 patent)

15. Sandrine Vialle-Blanc (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 7812006 - Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide (2010-10-12),

2. 7767658 - Vaccine composition (2010-08-03),

3. 7404960 - Multivalent vaccine composition having increased stability of capsular polysaccharide (2008-07-29),

4. 7320874 - [object Object] (2008-01-22),

5. 7122094 - Method and apparatus for sterile connection between two flexible tubes (2006-10-17),

6. 7056519 - Methods for inducing HIV-neutralizing antibodies (2006-06-06),

7. 6982088 - Vaccine composition and stabilization method using high molecular weight PVP (2006-01-03),

8. 6861253 - Polypeptide inducing antibodies neutralizing HIV (2005-03-01),

9. 6821723 - GP41 antigen (2004-11-23),

10. 6780421 - Adjuvant for a vaccine composition (2004-08-24),

11. 6737067 - Trimer of HIV env gene expression product (2004-05-18),

12. 6664049 - Method and device for cell lysis (2003-12-16),

13. 6641816 - Use of poxviruses as enhancer of specific immunity (2003-11-04),

14. 6610308 - Immunostimulant emulsion (2003-08-26),

15. 6596861 - Method for the reductive amination of polysaccharides (2003-07-22),

Company Overview

Aventis Pasteur S.A., headquartered in Lyon, France, is a prominent player in the field of vaccine development and manufacturing. The company specializes in creating innovative vaccines to combat infectious diseases, contributing significantly to global public health initiatives. With a strong focus on research and development, Aventis Pasteur leverages advanced technologies to enhance vaccine efficacy and safety. Its commitment to quality and innovation positions it as a leader in the biopharmaceutical industry, serving markets worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#25 in Lyon

#1,162 in France

#35,918 in the World

Aventis Pasteur S.a.

Forward Citations = 178

31 inventors:

Michel Chevalier (6 out of 9 patents)

Jean Haensler (3 out of 13 patents)

Monique Moreau (3 out of 10 patents)

4. Tino Krell (3 out of 3 patents)

5. Alain Françon (2 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aventis Pasteur S.a.. Retrieved from https://idiyas.com/company/aventis-pasteur-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…